Funds holding HARVARD BIOSCIENCE INC
ISIN US4169061052 · United States · LEI 549300VLGB1D47GGC642
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 233.2K $
- Share of capital
- 8.3 % of 4.6M shares on Aug 4, 2026
This issuer has other securities : Harvard Bioscience Inc (US4169062043)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 224,587 | 137.8K $ | 0.00 % | 4.93 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 70,173 | 43.1K $ | 1.54 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 55,562 | 34.1K $ | 1.22 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 29,367 | 18K $ | 0.00 % | 0.65 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 307 | 188.4 $ | 0.01 % | as of Feb 27, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | -6 | 379,996 | -81.6 % |
| 2026Q1 | 11 | -5 | 2,066,568 | -15.1 % |
| 2025Q4 | 16 | -44 | 2,433,353 | -48.9 % |
| 2025Q3 | 60 | -43 | 4,757,562 | -48.4 % |
| 2025Q2 | 103 | -16 | 9,222,863 | -9.5 % |
| 2025Q1 | 119 | -4 | 10,193,770 | -1.5 % |
| 2024Q4 | 123 | -2 | 10,346,362 | -6.4 % |
| 2024Q3 | 125 | 0 | 11,052,126 | +6.4 % |
| 2024Q2 | 125 | -3 | 10,390,723 | +3.4 % |
| 2024Q1 | 128 | -1 | 10,052,429 | +1.6 % |
| 2023Q4 | 129 | 9,897,974 |
Institutional managers
2 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Meros Investment Management, LP | 118,522 | 577.2K $ | as of Mar 31, 2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 117,500 | 572.2K $ | as of Mar 31, 2026 |
Declared shareholders of HARVARD BIOSCIENCE INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Leviticus Partners LP | 6.50 % | 293,676 | as of May 12, 2025 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding HARVARD BIOSCIENCE INC". https://titelia.com/en/stocks/harvard-bioscience-inc-US4169061052